Generics - Respiratory and Pulmonary, GlaxoSmithKline

Filter

Popular Filters

Regulatory briefs from GSK/Theravance, Allergan and Mylan

19-12-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) and US partner Theravance (Nasdaq: THRX0 have submitted a…

AllerganAnoro ElliptaBotoxEuropeGenericsGenito-urinaryGlaxoSmithKlineMylan LaboratoriesNorth AmericaPharmaceuticalQualaquinRegulationRelvarRespiratory and PulmonaryTheravanceTropical diseases

Mylan debuts generic Epivir in Europe; gets Canadian OK for Tracleer copy

07-06-2012

US generic drugs major Mylan (Nasdaq: MYL) says that its UK and Italy-based subsidiaries have launched…

ActelionAnti-viralsEpivirEuropeGenericsGlaxoSmithKlineMarkets & MarketingMylan LaboratoriesNorth AmericaRegulationRespiratory and PulmonaryTracleer

Mylan to acquire Pfizer generic respiratory delivery platform; challenge to GSK

10-11-2011

US generic drug major Mylan (Nasdaq: MYL) has entered into an agreement with global pharma behemoth Pfizer…

Advair DiskusGenericsGlaxoSmithKlineLicensingMylan LaboratoriesPfizerPharmaceuticalRespiratory and PulmonarySeretide

Teva gets BDP allergy drug NDA accepted by FDA; sued by ViiV over Epzicom

09-08-2011

The US Food and Drug Administration has accepted for filing Israeli generics giant Teva Pharmaceutical…

Anti-viralsEpzicomGenericsGlaxoSmithKlineLegalNorth AmericaPatentsPfizerPharmaceuticalRegulationRespiratory and PulmonaryTeva Pharmaceutical IndustriesViiV Healthcare

Back to top